Goto T, Kawai N, Bando T, Takasaki Y, et al. Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022-2023 season. Antiviral Res 2024;224:105853.
PMID: 38430970